Dr. Ali Afshar

Dr. Ali Afshar
Ali Afshar, MD, is an expert in robotic surgery with advanced training in complex urologic cancer surgery as well as minimally invasive techniques. He currently practices out of offices in Tarzana and West Hills. Dr. Afshar became interested in urology while doing oncology research at the Vanderbilt University Department of Urologic Surgery. He completed his urology residency at Cedars-Sinai Medical Center and continued his training with a fellowship in advanced endourology and robotic surgery at the world-renowned USC Norris Comprehensive Cancer Center at the University of Southern California. Having performed over 1000 robotic procedures, he has expertise in laparoscopic and robotic-assisted radical prostatectomy, radical nephrectomy, partial nephrectomy, nephroureterectomy, cystectomy, pyeloplasty, and many more. He also has expertise in treatment of BPH and offers array of options to patients including Aquablation. He is also one of the first to utilize new prostate cancer and BPH treatment option TULSA-PRO in western United States. Dr. Afshar has been practicing in San Fernando Valley since 2017 while also maintaining clinical privileges at Cedars-Sinai Medical Center, where he is an attending urologist and is actively involved with the current urology residency teaching program.

Languages Spoken:

English, Farsi

Medical School:

University of Tennessee Health Science Center School of Medicine


Cedars Sinai Medical Center


University of Southern California

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only